Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas MD Anderson Cancer Center · United States

Hagop M. Kantarjian

Hagop M. Kantarjian publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0002-1908-3307 OpenAlex
World rank
#62,381
of 7,710,434 ranked researchers
Rank in United States
#24,021
of 1,627,098
Works
5,585
Citations
273k
Citations per work
48.9
h-index
233
i10-index 2,531Top 0.1% in Hematology
Hagop M. Kantarjian

What does Hagop M. Kantarjian research?

Hagop M. Kantarjian's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 4,088 works · 73.2% of their workMedicine: 4,088 works · 73.2% of their workHematology: 1,983 works · 35.5% of their workGenetics: 1,011 works · 18.1% of their workPublic Health, Environmental and Occupational Health: 503 works · 9.0% of their workOncology: 330 works · 5.9% of their workRheumatology: 262 works · 4.7% of their workEverything else: 977 works · 17.5% of their workLife Sciences: 519 works · 9.3% of their workBiochemistry, Genetics and Molecular Biology: 519 works · 9.3% of their workMolecular Biology: 519 works · 9.3% of their workTHEIR WORKHagop M.Kantarjian5,585works
Life Sciences9%Health Sciences73%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Health Sciences4,08873.2%
    1. Medicine4,08873.2%
  2. Everything else97717.5%
    1. Biochemistry, Genetics and Molecular Biology5199.3%
  1. 1Hematology36% of their works
  2. 2Genetics18% of their works
  3. 3Molecular Biology9% of their works
  4. 4Public Health, Environmental and Occupational Health9% of their works
  5. 5Oncology6% of their works
  6. 6Rheumatology5% of their works

Research topics

Which keywords describe Hagop M. Kantarjian's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, Rituximab, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors5,4973 topics
  2. AML2,4341 topic
  3. Acute Myeloid Leukemia2,4341 topic
  4. BCR-ABL2,2931 topic
  5. Imatinib2,2931 topic
  6. Rituximab2,1992 topics
  7. Chronic Lymphocytic Leukemia1,7461 topic
  8. Genomic Aberrations1,7461 topic
  9. Acute Lymphoblastic Leukemia1,3171 topic
  10. Childhood Cancer1,3171 topic
  11. Classification1,1362 topics
  12. JAK2 Mutation8581 topic
  13. Myelofibrosis8581 topic
  14. Fusion Genes6831 topic
  15. Hypereosinophilic Syndrome6831 topic
  16. Lymphoma4531 topic
  17. Molecular Profiling4531 topic
  18. HDAC Inhibitors3041 topic
  19. Histone Deacetylases3041 topic

Where does Hagop M. Kantarjian work?

Hagop M. Kantarjian's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.

How many publications and citations does Hagop M. Kantarjian have?

OpenAlex counts 5,585 works and 273,266 citations for Hagop M. Kantarjian, an h-index of 233, ranking #62,381 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Hagop M. Kantarjian

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hagop M. Kantarjian. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.